IntelliSpace Precision Medicine Oncology Pathways

Encompasses the expertise of over 300 oncologists, scientists, pharmacists and a team of data scientists and informatics experts at Dana-Farber Cancer Institute.

Automatically recommend local and national clinical trials for patients based on a variety of factors, including cancer type, specific biomarkers, prior therapies, and comorbidity status.

Interactive navigation and advanced visualization of a decision tree based on the patient profile. Built with Oncologists for Oncologists, reflecting the way oncologists think.